The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …

The corona virus disease 2019 (COVID-19) global pandemic has had an unprecedented
and persistent impact on oncological practice, especially for patients with lung cancer, who …

Immunotherapy is now established as a potent therapeutic paradigm engendering antitumor
immune response against a wide range of malignancies and other diseases by modulating …

Patients with cancer generally have a higher risk of adverse outcomes from COVID-19, with
higher age, male sex, poor performance status, cancer type, and uncontrolled malignant …

Objectives To date, studies have not provided definitive answers regarding whether
previous immune checkpoint inhibitor (ICI) treatment alters outcomes for cancer patients with …

The exact impact of immune checkpoint inhibitors in the course and outcome of COVID-19 in
cancer patients is currently unclear. Herein, we present the first description of an elderly …

Background Despite immunization, patients on antineoplastic and immunomodulating
agents have a heightened risk of COVID-19 infection. However, accurately attributing this …

A vital function of the immune system is the modulation of an evolving immune response. It is
responsible for guarding against a wide variety of pathogens as well as the establishment of …

近期2019 新型冠状病毒变异毒株奥密克戎BA. 2 亚型在全球大流行, 对人民的生命安全造成了
较大的影响. 肿瘤患者因疾病自身或治疗的原因处于免疫失衡状态, 更易罹患2019 冠状病毒病 …

γδ T cells are unconventional cells involved in innate and adaptive immunity. They are able
to respond rapidly and have roles in a range of diseases. The tuberculosis (TB) vaccine …